Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization

被引:9
|
作者
Cheville, JC
Bromley, C
Argenyl, ZB
机构
[1] UNIV IOWA HOSP & CLIN,IOWA COLL MED,DEPT PATHOL,DERMATOPATHOL UNIT,IOWA CITY,IA 52242
[2] UNIV IOWA HOSP & CLIN,IOWA COLL MED,DEPT DERMATOL,IOWA CITY,IA 52242
关键词
D O I
10.1111/j.1600-0560.1995.tb01149.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keratoacanthoma (KA) is generally considered to be a clinically and histologically distinct entity, but it often remains difficult to separate from well-differentiated squamous cell carcinoma (WDSCC). Recently, trisomy 7 has been identified in squamous cell carcinoma of the skin. In this study, we examined classical KA (n=6), WDSCC (n=8) and squamous cell carcinoma with KA-like features (SCC-KA) (n=8) for trisomy 7 by fluorescence in-situ hybridization (FISH) to determine if this chromosomal abnormality is unique to squamous lesions diagnosed as WDSCC, or shared by both KA and SCC. In addition, the pertinent clinical-histopathologic findings were summarized. Trisomy 7 was identified in one KA, one SCC-KA and two WDSCC. This study by KA and SCC, providing further evidence that KA is most likely a form of SCC. Further studies are required to determine if trisomy 7 in these lesions is of prognostic significance.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 50 条
  • [21] CRYOTHERAPY FOR SQUAMOUS CELL CARCINOMA IN-SITU
    Kuo, E.
    Prasad, J.
    Farmer, M.
    RESPIROLOGY, 2015, 20 : 148 - 148
  • [22] Keratoacanthoma vs. squamous cell carcinoma in contrast with keratoacanthoma is squamous cell carcinoma -: Response
    Forslund, O
    DeAngelis, PM
    Beigi, M
    Schjolberg, AR
    Clausen, OPF
    JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (03) : 292 - 293
  • [23] PARTIAL TRISOMY 13Q IDENTIFIED BY SEQUENTIAL FLUORESCENCE IN-SITU HYBRIDIZATION
    RAO, VVNG
    CARPENTER, NJ
    GUCSAVAS, M
    COLDWELL, J
    SAY, B
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (01): : 50 - 53
  • [24] FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS OF TRISOMY-12 IN OVARIAN-TUMORS
    PERSONS, DL
    HARTMANN, LC
    HERATH, JF
    KEENEY, GL
    JENKINS, RB
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) : 775 - 779
  • [25] DETECTION OF MONOSOMY-7 AND TRISOMY-8 IN MYELOID NEOPLASIA - A COMPARISON OF BANDING AND FLUORESCENCE IN-SITU HYBRIDIZATION
    KIBBELAAR, RE
    MULDER, JWR
    DREEF, EJ
    VANKAMP, H
    FIBBE, WE
    WESSELS, JW
    BEVERSTOCK, GC
    HAAK, HL
    KLUIN, PM
    BLOOD, 1993, 82 (03) : 904 - 913
  • [26] A COMPLEX CHROMOSOMAL REARRANGEMENT DETECTED PRENATALLY AND STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZATION
    BATISTA, DAS
    TUCKMULLER, CM
    MARTINEZ, JE
    KEARNS, WG
    PEARSON, PL
    STETTEN, G
    HUMAN GENETICS, 1993, 92 (02) : 117 - 121
  • [27] FLUORESCENCE IN-SITU HYBRIDIZATION FOR THE DETECTION OF TRISOMY-8 AND TRISOMY-9 IN POLYCYTHEMIA-VERA
    AMIEL, A
    GABER, E
    MANOR, Y
    FEJGIN, M
    JOSEPHLERNER, N
    RAVID, M
    LISHNER, M
    CANCER GENETICS AND CYTOGENETICS, 1995, 79 (02) : 153 - 156
  • [28] A case of intraepidermal Merkel cell carcinoma within squamous cell carcinoma in-situ: Merkel cell carcinoma in-situ?
    Al-Ahmadie, HA
    Matusim, DF
    Mutema, GK
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2004, 26 (03) : 230 - 233
  • [29] CHROMOSOME-17 ANALYSIS OF DUCTAL CARCINOMA IN-SITU OF THE BREAST BY FLUORESCENCE IN-SITU HYBRIDIZATION
    MURPHY, DS
    GEORGE, WD
    KAYE, SB
    KEITH, WN
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1807 - 1807
  • [30] CYTOGENETIC CHARACTERIZATION OF A BLADDER-CARCINOMA CELL-LINE BY FLUORESCENCE IN-SITU HYBRIDIZATION
    WANG, MR
    PERISSEL, B
    MALET, P
    CANCER GENETICS AND CYTOGENETICS, 1995, 82 (02) : 170 - 174